Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...

Indian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lo...

Bain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...

The Supreme Court has ruled in favor of the Maharashtra government. Companies will now have to pay electricity duty on power generated by t...

Sunsure Energy has signed an agreement to supply 21MW solar power to Lupin's Tarapur facility from its 100 MW solar plant in Solapur. This ...

According to FDA's definitions, Official Action Indicated means "objectionable conditions were found and regulatory administrative sanction...

Sell Lupin at a price target of Rs 800.

"Non-sterile plants getting stuck for such a long time are really surprising."

The warning letter was issued on Monday for Pithampur unit II of Indore and its Goa plant.

Drug firm Lupin today said US health regulator has voiced minor concerns after completing the inspection of its Dabhasa facility in Gujarat.

However, the company said the observations were "minor in nature" and would not lead to any disruption of product supply from the location.

"We wish to state that the USFDA inspected company's Goa facility last week and cited nine observations," Lupin said in a regulatory filing.

Kyowa Pharmaceutical Industry Co is a wholly-owned subsidiary of the the Mumbai-based firm. It has a manufacturing facility at Sanda, Japan.

Natural toxins in nectar and pollen can poison insects and affect their memory, behaviour and reproductive success, researchers have found.

Drug maker Lupin has received clearance from the US drug regulator for its plant at Mandideep in Madhya Pradesh, allowing the Mumbai-based ...

The US Food and Drug Administration (USFDA) has found 15 manufacturing deficiencies at one of Lupin’s plant in Madhya Pradesh (MP) during t...

Pharma major Lupin proposes to set up a sector-specific Special Economic Zone (SEZ) in Maharashtra to produce API and formulations with an ...